Sustainable Week: Fixing Our Broken Moral Compass
By Chuck Stern,
BTRtoday
| 07. 08. 2016
[citing CGS’ Elliot Hosman]
What if we could fix a broken moral compass? According to bioethicist and sociologist James J. Hughes of the Institute for Ethics and Emerging Technologies, we're already there.
In a provocative piece published in the Washington Post last month, Hughes cites dopamine-stimulating ADHD medications as current examples of "moral enhancement," and argues that other treatments like gene therapies and implants will soon follow, even if usage "will not be voluntary."
If this sounds unsettling, you are not alone. Elliot Hosman of the Center for Genetics and Society, who previously spoke to BTRtoday about this "socially dangerous" slope, weighs in on Hughes' claims.
Hosman believes that the field of behavioral genetics is fraught with biases, mishaps, and "conflicts of interest that warp the scientific process." They assert that Hughes' characterizations are "reductive" in the way that they misrepresent the nuances of the field; while Hughes believes that "criminality" and "sexual promiscuity" are genetically predetermined, Hosman insists that this is contradicted by both genetics and the social sciences. They further warn of "genetic determinism," the notion that there is "inherent value" in...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
